Competition & Markets Authority
CMA opens investigation into NHS hospital trusts merger
The CMA yesterday started an investigation into the proposed merger between NHS hospital trusts in Poole and Bournemouth.
In 2013, the Competition and Markets Authority’s (CMA) predecessor, the Competition Commission, prohibited a previous merger between the Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust and Poole Hospital NHS Foundation Trust. As a result, the hospital trusts were required to enter into a 10-year commitment not to merge without the prior approval of the CMA.
Since the Competition Commission’s decision, there have been significant changes to policy within the NHS that have affected the role that competition plays. Competition between NHS hospitals is no longer used by the NHS to drive quality, with collaboration often viewed as a better way to meet increasing demands for care and deliver better value.
This has been taken into account in recent hospital mergers reviewed by the CMA, including the merger between Aintree University Hospital NHS Foundation Trust and The Royal Liverpool and Broadgreen University Hospitals NHS Trust, which was cleared in August 2019.
The CMA’s assessment of the potential effects of this merger on NHS services in the east Dorset area will take these policy changes into account. During the investigation, the CMA will work closely with Bournemouth and Poole Hospital trusts, the NHS regulators and local commissioners to assess the role that competition plays in how the hospitals provide services and whether any loss of competition brought about by the merger could have a negative impact on patients.
The CMA is also inviting views on these issues from patients and their representative groups, commissioning groups, other healthcare providers, regulators, local authorities and other interested bodies.
More broadly, the CMA is aware of longer-term NHS plans to exempt mergers between NHS hospitals from CMA review, which it fully supports.
For more information, visit the CMA’s dedicated webpage for the Royal Bournemouth and Christchurch Hospitals / Poole Hospital NHS Foundation Trusts merger investigation.
For media enquiries, contact the CMA press team on 020 3738 6460 or email@example.com.
Latest News from
Competition & Markets Authority
Competition concerns remain about FNZ’s purchase of GBST15/04/2021 15:10:00
The CMA has provisionally found that a deal between FNZ and GBST would raise significant competition concerns, following its re-examination of available evidence.
CMA provisionally clears merger of Virgin and O214/04/2021 10:15:00
The CMA has provisionally cleared the proposed merger of Virgin Media and Virgin Mobile with O2.
CMA intervention leads to further Facebook action on fake reviews09/04/2021 11:20:00
CMA action results in Facebook going further to combat the trading in fake and misleading reviews on Facebook.com and Instagram.com.
New watchdog to boost online competition launches07/04/2021 12:22:00
A tough new regulator to help make sure tech giants such as Facebook and Google cannot exploit their market dominance to crowd out competition and stifle innovation online has launched.
CMA clears Uber and Autocab deal30/03/2021 12:20:00
The CMA yesterday announced that it has cleared Uber’s purchase of Autocab, following a Phase 1 merger investigation.
CMA secures over £500k for Argos extended warranty customers29/03/2021 12:20:00
Argos has agreed to fix the way it sells extended warranties to customers and provide a goodwill gesture to those who may have missed out on a better deal.
Crowdcube and Seedrs abandon merger during CMA investigation26/03/2021 16:43:00
Crowdcube and Seedrs have abandoned their proposed tie-up after the CMA provisionally blocked the deal.
Facebook’s purchase of Giphy raises competition concerns26/03/2021 12:20:00
The CMA has found that Facebook’s completed acquisition of Giphy raises competition concerns in relation to digital advertising and the supply of GIFs.